Why I'm Still Avoiding Dendreon
Is Dendreon's multi-year epic decline reaching an end, or is there more to come?
Biotech 101: Breakthrough Therapy
BreakthroughtTherapy designation is a term that investors in drugmakers, such as Novartis, Medivation, and Sarepta Therapeutics need to understand.
Biotech Stock Roundup: Medivation Gains on Xtandi Strength, Amgen Scores in Late-Stage Study - Anal
Biotech Stock Roundup: Medivation Gains on Xtandi Strength, Amgen Scores in Late-Stage Study - Analyst Blog
Is Dendreon Back on Solid Ground?
Dendreon (DNDN) faces stiff competition from Johnson & Johnson (JNJ) and Medivation (MDVN), but a significant restructuring is lopping off costs in a bid to make the company profitable.
What You Need to Know About Medivation Inc.'s Results
Medivation (MDVN) and Astellas (ALPMY) saw U.S. sales growth slow this quarter, but growth overseas took off. Here's what could be in store for these stocks through the rest of the year.